Biora Therapeutics Inc. (BIOR:OTC) closed at $0.220 on January 23, 2026, unchanged on the day. The stock trades 42.1% below its 52-week high of $0.380 and 46.7% above its 52-week low of $0.150. Biora Therapeutics Inc. is part of the Health Care sector.
Biora Therapeutics Inc, formerly Progenity Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology. Geographically, it operates only in the United States. It generates revenue from providing molecular laboratory tests to customers.
Find more stocks like BIOR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.